Write A 175- To 265-Word Response To The Questions 038190 ✓ Solved
Write a 175- to 265-word response to the following questions
Write a 175- to 265-word response to the following questions: What are some common diseases that have an impact on the cardiovascular system? Pick one from this week's reading and list the causes. What diseases have an impact on the respiratory system? Pick one from this week's reading and list the causes. How will the knowledge help you as a health care manager? Minimum 1 reference in APA format. You can use the class textbook or other valid references.
Paper For Above Instructions
Cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for millions of fatalities each year and placing substantial demand on health systems and economies. The burden of CVD is not only a function of clinical outcomes but also of prevention, timely diagnosis, and effective management across diverse populations (American Heart Association, 2023; World Health Organization, 2023). Within this spectrum, coronary artery disease (CAD) is the most prevalent manifestation of atherosclerotic disease and a major contributor to myocardial infarction and heart failure (National Heart, Lung, and Blood Institute, 2023). CAD arises from a complex interplay of modifiable and non-modifiable factors, with atherosclerotic plaque formation driven by lipid deposition, endothelial dysfunction, and chronic inflammation (Libby, Ridker, & Hansson, 2011). Key modifiable risk factors include elevated low‑density lipoprotein cholesterol, hypertension, cigarette smoking, diabetes mellitus, obesity, physical inactivity, and an unhealthy diet, all of which accelerate plaque buildup and thrombosis risk (American Heart Association, 2023; NHLBI, 2023). Non-modifiable risks such as age, family history, and certain genetic predispositions further elevate risk, underscoring the need for personalized prevention strategies (AHA, 2023). The translation of this knowledge into practice is essential for managers overseeing cardiovascular care programs, where prevention, early detection, and coordinated care can reduce admissions and improve outcomes (WHO, 2023).
On the respiratory side, asthma is a common chronic inflammatory disease of the airways that affects both children and adults and poses substantial management challenges in primary and specialty care (GINA, 2023; NHLBI, 2023). Asthma causes include a genetic predisposition toward atopy, environmental triggers, and inflammatory pathways that lead to airway hyperresponsiveness and reversible obstruction. Atopy (a tendency to develop IgE-mediated responses to common allergens) interacts with environmental exposures—such as indoor and outdoor air pollutants, tobacco smoke, viral infections, and occupational irritants—to provoke episodic symptoms, bronchial hyperreactivity, and variable airflow limitation (CDC, 2022; NHLBI, 2023). Obesity and hormonal factors can also influence disease severity and control. Understanding these etiologies supports targeted interventions, including trigger avoidance, appropriate pharmacotherapy (inhaled corticosteroids, bronchodilators), and patient education to optimize daily control and reduce exacerbations (GINA, 2023; NHLBI, 2023; CDC, 2022). A healthcare manager who grasps these mechanisms can design integrated asthma programs, coordinate multidisciplinary teams, and align resources with population needs (GOLD, 2023; EPA, 2021).
How will this knowledge help you as a health care manager? First, it enables risk stratification and proactive care planning. By recognizing the shared and distinct risk factors for CVD and respiratory disease, managers can implement screening protocols, lifestyle‑ modification programs, and early intervention strategies that target high‑risk patients and communities with greater disease burden (AHA, 2023; WHO, 2023). Second, it supports the design of care pathways that promote preventive care, adherence to guideline‑concordant therapies, and timely referrals to specialists, reducing preventable hospitalizations and improving patient outcomes (NHLBI, 2023; GINA, 2023). Third, the knowledge informs resource allocation and workforce development. Training clinicians in evidence‑based risk reduction, patient education, and care coordination—along with investing in home‑based management, telehealth, and community health programs—can enhance access, adherence, and monitoring (GOLD, 2023; EPA, 2021). Finally, these insights emphasize the importance of environmental and social determinants. Addressing air quality, occupational exposures, and social support systems can reduce disease exacerbations and improve population health (CDC, 2022; WHO, 2023).
References
- American Heart Association. (2023). Heart Disease and Stroke Statistics—2023 Update. Circulation, 147(8), e1–e210.
- World Health Organization. (2023). Cardiovascular diseases. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
- National Heart, Lung, and Blood Institute. (2023). Coronary Heart Disease. https://www.nhlbi.nih.gov/health-topics/coronary-heart-disease
- National Heart, Lung, and Blood Institute. (2023). Asthma. https://www.nhlbi.nih.gov/health-topics/asthma
- Centers for Disease Control and Prevention. (2022). Asthma Facts. https://www.cdc.gov/asthma/basics/index.html
- Global Initiative for Chronic Obstructive Lung Disease. (2023). GOLD 2023 Report. https://goldcopd.org/gold-reports/
- U.S. Environmental Protection Agency. (2021). Air Pollution and Public Health. https://www.epa.gov/air-pollution-health
- Mayo Clinic. (2023). Coronary artery disease. https://www.mayoclinic.org/diseases-conditions/coronary-artery-disease/symptoms-causes/syc-20370525
- Libby, P., Ridker, P. M., & Hansson, G. K. (2011). Inflammation in atherosclerosis: From pathophysiology to new therapies. Nature, 473(7347), 316–324.
- Global Initiative for Asthma. (2023). Global Strategy for Asthma Management and Prevention (GINA) 2023 Update. https://ginasthma.org/